Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
The landscape of ulcerative colitis has changed in the last two decades. Advancements in pharmacotherapeutics have heralded the introduction of new treatment options, with many agents in development. Better clinical outcomes are seen with tighter disease control, made possible with greater understan...
Saved in:
Main Authors: | Shu Wen Tay, Kevin Kim Jun Teh, Tiing-Leong Ang, Malcolm Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer – Medknow Publications
2024-02-01
|
Series: | Singapore Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.11622/smedj.2021173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
by: Magdalena Kaniewska, et al.
Published: (2017-09-01) -
Associations between an gene polymorphism and ulcerative colitis by ARMS-PCR
by: Mahsa Sadat Hashemi Doulabi, et al.
Published: (2020-03-01) -
Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01) -
Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptoms
by: Najmeh Oliyaei, et al.
Published: (2025-02-01) -
Characteristic features of ulcerative colitis with
concomitant primary sclerosing cholangitis
by: Artur W. Uździcki, et al.
Published: (2021-09-01)